C Sarfas
Overview
Explore the profile of C Sarfas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fenn J, Ridgley L, White A, Sarfas C, Dennis M, Dalgleish A, et al.
Clin Exp Immunol
. 2022 Apr;
208(3):301-315.
PMID: 35404420
Vδ2+ T cells can recognize malignantly transformed cells as well as those infected with mycobacteria. This cross-reactivity supports the idea of using mycobacteria to manipulate Vδ2+ T cells in cancer...
2.
Tipton T, Hall Y, Bore J, White A, Sibley L, Sarfas C, et al.
Nat Commun
. 2021 Feb;
12(1):1153.
PMID: 33608536
Zaire ebolavirus (EBOV) is a highly pathogenic filovirus which can result in Ebola virus disease (EVD); a serious medical condition that presents as flu like symptoms but then often leads...
3.
Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, et al.
Tuberculosis (Edinb)
. 2016 Nov;
101:174-190.
PMID: 27865390
Intradermal (ID) BCG injection provides incomplete protection against TB in humans and experimental models. Alternative BCG vaccination strategies may improve protection in model species, including rhesus macaques. This study compares...
4.
White A, Sarfas C, West K, Sibley L, Wareham A, Clark S, et al.
Clin Vaccine Immunol
. 2015 Jun;
22(9):992-1003.
PMID: 26108288
Nine million cases of tuberculosis (TB) were reported in 2013, with a further 1.5 million deaths attributed to the disease. When delivered as an intradermal (i.d.) injection, the Mycobacterium bovis...